Old Mission Investment Co’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$411K Hold
3,253
– – 0.09% 96
2026
Q1
$453K Sell
3,253
-19
-0.6% -$2.66K 0.11% 87
2025
Q4
$402K Buy
3,272
+19
+0.6% +$2.31K 0.1% 85
2025
Q3
$361K Buy
+3,253
New +$370K 0.09% 93
2024
Q1
– Sell
-2,675
Closed -$217K – 119
2023
Q4
$217K Hold
2,675
– – 0.08% 110
2023
Q3
$200K Sell
2,675
-27
-1% -$2.08K 0.08% 111
2023
Q2
$208K Buy
2,702
+32
+1% +$2.55K 0.08% 110
2023
Q1
$222K Sell
2,670
-50
-2% -$4.14K 0.09% 105
2022
Q4
$234K Buy
+2,720
New +$215K 0.1% 101

Other funds holding GILD

Old Mission Investment Co's GILD Position: Q2 2026 in Review

Old Mission Investment Co held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,253 shares worth $411K. The position accounts for 0.09% of the portfolio, ranked #96.

Old Mission Investment Co first reported a position in GILD in Q4 2022 and has held it in 9 quarters since. The position peaked at $453K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Old Mission Investment Co held 3,253 shares of Gilead Sciences worth $411K as of Q2 2026.
  • Old Mission Investment Co left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.09% of Old Mission Investment Co's portfolio in Q2 2026, its #96 holding.
  • Old Mission Investment Co first reported a position in Gilead Sciences in Q4 2022 and has held it in 9 quarters since.
  • Old Mission Investment Co's Gilead Sciences position peaked at $453K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Old Mission Investment Co's 13F filing for Q2 2026, filed 14 Aug 2026.